Treatment(s) already received-Radical prostatectomy - Page 2 of 5 Posts on Medivizor
Navigation Menu

Treatment(s) already received-Radical prostatectomy Posts on Medivizor

Can the ProACT™ surgical implant help with stress urinary incontinence after surgery for prostate cancer?

Posted by on Sep 9, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the use of a surgical implant, in improving quality of life and side-effects of stress urinary incontinence after prostate cancer surgery. This study found that this implant led to significant improvements in quality of life in these patients. Some background Stress urinary incontinence (SUI) is the...

Read More

Searching for men with high-risk, relapsed prostate cancer to test the use of anti-hormonal medication

Posted by on Aug 31, 2018 in Prostate cancer | 0 comments

In a nutshell This trial is examining the effectiveness of different hormone therapy regimes for patients whose prostate-specific antigen (PSA; a protein elevated in prostate cancer) levels rise after prostate removing surgery. The main outcome to be measured will be the change in PSA levels. The details The best standard treatment for...

Read More

Looking for patients with prostate cancer who have had a rise in PSA after prostate removal surgery

Posted by on Aug 31, 2018 in Prostate cancer | 0 comments

In a nutshell This trial is examining the effectiveness of different hormone therapy regimes for patients whose prostate specific antigen (PSA; a protein elevated in prostate cancer) levels rise after prostate removing surgery. The main outcome to be measured will be the change in PSA levels.   The details The best standard treatment...

Read More

Can PET/CT scanning guide radiotherapy treatment in prostate cancer?

Posted by on Aug 13, 2018 in Prostate cancer | 0 comments

In a nutshell This paper studied if a targeted form of radiotherapy could be effective in improving patient outcomes after surgical treatment of prostate cancer. The main finding was that a specific type of radiotherapy using PET scans improved outcomes in these patients. Some background Prostate specific antigen is a chemical in the blood that has...

Read More

Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer.

Posted by on Mar 5, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to identify risk factors of recurrence after prostatectomy in high risk patients. Patients with more risk factors were more likely to experience disease recurrence at five years. Some background Prostatectomy is a treatment option for prostate cancer. The prostate tumor is surgically removed. There are several risk...

Read More

PSA response after cabazitaxel treatment is associated with improved progression-free survival in men with metastatic castration-resistant prostate cancer.

Posted by on Jan 26, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to examine the links between prostate specific antigen (PSA, a protein present in prostate cancer) and survival in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel. This studty concluded that PSA response after cabazitaxel treatment is associated with improved...

Read More

An analysis of abiraterone plus prednisone for metastatic castration-resistant prostate cancer

Posted by on Nov 8, 2017 in Prostate cancer | 0 comments

In a nutshell This study aimed to determine which patients  benefited most from abiraterone acetate (Zytiga) and prednisone (Deltasone). This study found that overall survival was increased for all patient groups that received this combination.  Some background A main treatment option for prostate cancer is androgen deprivation...

Read More

Proteins in the prostate gland can help predict disease recurrence after surgery

Posted by on May 15, 2017 in Prostate cancer | 0 comments

In a nutshell This study examined if the collections of proteins in the prostate can predict prostate surgery outcomes. Authors found that protein analysis was a significant predictor of disease recurrence and metastasis (cancer spread) after surgery. Some background Prostate surgery is a first-line treatment option for prostate cancer. It has...

Read More

Radium 223-dichloride as a treatment for castration resistant prostate cancer

Posted by on Apr 3, 2017 in Prostate cancer | 0 comments

In a nutshell This study investigated how effective and safe radium 223 dichloride treatment was in patients with castration resistant prostate cancer (CRPC). It was concluded that radium 223 dichloride increased overall survival, reduced symptomatic skeletal events risk and was safe.  Some background Treatment to decrease the male hormones,...

Read More

Looking for overweight or obese prostate cancer patients with disease progression after primary therapy

Posted by on Feb 6, 2017 in Prostate cancer | 0 comments

In a nutshell This phase 2 trial aims to evaluate the benefit of adding metformin (Glucophage) to hormone therapy with bicalutamide (Casodex). The main outcome to be investigated is treatment response. The trial is recruiting in Philadelphia (Pennsylvania), USA. The details Obesity and metabolic syndrome (a collection of conditions including...

Read More